Gestalt Diagnostics website ensures accessibility and compliance for all

SPOKANE, Wash., May 20, 2022 /PRNewswire/ — Leading provider of digital pathology solutions, Gestalt Diagnostics, Inc today announces the relaunch of its website with built-in user-triggered accessibility features. This feature provides new ways for users with disabilities to browse, log in and access Gestalt’s solutions and website in a way that works best for them. At the forefront of solving healthcare workflow issues, Gestalt recognizes that being accessibility aware means adapting to our users who need different accessibility options every day.

“We are delighted to announce that, in line with healthcare accessibility initiatives put in place for healthcare technology companies, we are working to make our solutions and services accessible to everyone,” said the director of operations and strategy director of Gestalt, Lisa Jean Clifford. “It is paramount that health technology companies remain compliant and strive to make accessibility easy and seamless for everyone. Transforming the pathology workflow through intuitive and interoperable digital solutions is our mission. Offering specialized features on our website allows our partners and customers to interact with us in the best way for them.”

About Gestalt Diagnostics
Gestalt Diagnostics transforms pathology with an intelligent, configurable, vendor-neutral, AI-driven digital workflow that delivers true interoperability enabling pathologists to diagnose diseases faster and more efficiently. Our PathFlow® solution is a cloud-based digital pathology enterprise platform that can easily be customized to your specific preferences. Our platform consists of professional, educational and research modules to make it easy to mix and match your institution’s digital needs in a single solution, freeing pathologists from tedious, repetitive and manual tasks allowing them to focus on their expertise, providing invaluable experience where it matters most.

SOURCEGestalt Diagnostics

Comments are closed.